Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
World Neurosurg. 2024 Apr;184:e144-e153. doi: 10.1016/j.wneu.2024.01.073. Epub 2024 Jan 20.
This study aimed to evaluate the clinical course after flow diversion (FD) treatment with a focus on aneurysms with remnant sac filling, by analyzing angiographic outcomes, aneurysm volume, and clinical events.
We retrospectively reviewed the medical records of 61 patients who underwent FD for intracranial aneurysms between July 2014 and June 2021.
The majority of aneurysms (52.5%) were located in the internal carotid artery, with a median diameter of 16.6 mm and neck size of 9.3 mm. Remnant filling was observed in 17 aneurysms (27.9%) more than 18 months after FD, 10 (16.4%) of these aneurysms underwent enlargement, which occurred only in cases with subtotal filling or entry remnant states. Eleven patients experienced major adverse events, and three exhibited unfavorable functional outcomes. The incidence of major adverse events and unfavorable functional outcomes was significantly higher in the aneurysm enlargement group than that in the no-filling or stable remnant filling groups (P < 0.001). Aneurysmal diameter and the presence of incorporated branches were independent predictors of aneurysm enlargement, while the presence of incorporated branches was the only independent predictor of persistent remnant filling.
Aneurysm enlargement after FD is not uncommon, particularly when the aneurysm is large, has incorporated vessels, or does not undergo occlusion within 12 months, often culminating in major adverse events and unfavorable functional outcomes. In addition to investigating angiographic results, it is necessary to evaluate the changes in aneurysm size and clinical events when assessing the efficacy of FD.
本研究旨在通过分析血管造影结果、动脉瘤体积和临床事件,评估血流导向装置(FD)治疗后残留瘤腔填充的临床病程,重点关注残留瘤腔填充的动脉瘤。
我们回顾性分析了 2014 年 7 月至 2021 年 6 月期间 61 例接受 FD 治疗颅内动脉瘤患者的病历。
大多数动脉瘤(52.5%)位于颈内动脉,瘤颈中位数为 16.6mm,瘤颈大小为 9.3mm。FD 后 18 个月以上发现 17 个动脉瘤(27.9%)存在残留填充,其中 10 个(16.4%)发生了增大,仅在部分填充或入口残余状态下发生。11 例患者发生主要不良事件,3 例患者出现不良功能结局。在动脉瘤增大组中,主要不良事件和不良功能结局的发生率明显高于无填充或稳定残留填充组(P<0.001)。动脉瘤直径和包含分支的存在是动脉瘤增大的独立预测因素,而包含分支的存在是残留填充持续存在的唯一独立预测因素。
FD 后动脉瘤增大并不少见,特别是当动脉瘤较大、存在吻合血管或 12 个月内未闭塞时,常导致严重不良事件和不良功能结局。除了研究血管造影结果外,在评估 FD 疗效时还需要评估动脉瘤大小和临床事件的变化。